Whipplewood Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.98K Buy
+17
New +$5.59K ﹤0.01% 618
2025
Q3
Sell
-24
Closed -$9.34K 566
2025
Q2
$9.34K Buy
24
+13
+118% +$5.23K 0.01% 577
2025
Q1
$10K Sell
11
-13
-54% -$5.22K 0.01% 566
2024
Q4
$8.85K Buy
+24
New +$10K 0.01% 573

Other funds holding ELV

Whipplewood Advisors's ELV Position: Q1 2026 in Review

Whipplewood Advisors opened a new position in Elevance Health (ELV) in Q1 2026: 17 shares worth $4.98K. The stake represents ﹤0.01% of the portfolio and ranks #618 among its holdings. This is a return to the name: Whipplewood Advisors previously reported a position in ELV as recently as Q2 2025.

Whipplewood Advisors first reported a position in ELV in Q4 2024 and has held it in 4 quarters since. The position peaked at $10K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Whipplewood Advisors held 17 shares of Elevance Health worth $4.98K as of Q1 2026.
  • Elevance Health was a new Whipplewood Advisors position in Q1 2026.
  • Elevance Health made up ﹤0.01% of Whipplewood Advisors's portfolio in Q1 2026, its #618 holding.
  • Whipplewood Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 4 quarters since.
  • Whipplewood Advisors's Elevance Health position peaked at $10K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Whipplewood Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.